Get the Stockscreener App
4.725
0.32%
-0.015
Profound Medical Corp stock is traded at $4.725, with a volume of 1,475.
It is down -0.32% in the last 24 hours and down -16.81% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$4.74
Open:
$4.72
24h Volume:
1,475
Relative Volume:
0.02
Market Cap:
$142.00M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-3.5261
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
-0.53%
1M Performance:
-16.81%
6M Performance:
-33.45%
1Y Performance:
-47.67%
1-Day Range:
$4.72
$4.725
1-Week Range:
$4.3144
$4.835
52-Week Range:
$3.895
$9.38
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
4.725 | 142.75M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
132.03 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.70 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.61 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.60 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
82.02 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Is it too late to sell Profound Medical Corp.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Will Profound Medical Corp. outperform the marketMarket Performance Report & Daily Market Momentum Tracking - Newser
Evaluating Profound Medical Corp. with trendline analysisQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Leading vs lagging indicators on Profound Medical Corp. performanceMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Volatility clustering patterns for Profound Medical Corp.July 2025 Momentum & AI Enhanced Execution Alerts - Newser
What candlestick patterns are forming on Profound Medical Corp.2025 Market Overview & Precise Buy Zone Tips - Newser
Custom watchlist performance reports with Profound Medical Corp.2025 Market Overview & Fast Moving Stock Watchlists - Newser
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript - MSN
Published on: 2025-08-19 16:58:38 - Newser
Is now a turning point for Profound Medical Corp.2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Analysts Spot Bullish Divergence in Profound Medical Corp.Weekly Market Summary & Consistent Profit Trading Strategies - newsyoung.net
Profound Medical is a buy, Leede says - Cantech Letter
Using Bollinger Bands to evaluate Profound Medical Corp.Buy Signal & Safe Capital Investment Plans - Newser
How hedge fund analytics apply to Profound Medical Corp. stock2025 Earnings Impact & Step-by-Step Trade Execution Guides - Newser
How sentiment analysis helps forecast Profound Medical Corp.2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence - MSN
Profound Medical: Smokes Is Everywhere, Initiate At Sell (NASDAQ:PROF) - Seeking Alpha
Is Profound Medical Corp. Forming a Bottom PatternLong Setup & Scalable Portfolio Growth Methods - sundaytimes.kr
Why Profound Medical Corp. stock attracts strong analyst attentionWatch List & Community Verified Trade Alerts - 선데이타임즈
Published on: 2025-08-18 05:28:45 - beatles.ru
Detecting support and resistance levels for Profound Medical Corp.2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
Using fundamentals and technicals on Profound Medical Corp.Recession Risk & Low Risk High Reward Ideas - Newser
Will Profound Medical Corp. announce a stock split2025 Winners & Losers & Real-Time Volume Analysis - mustnews.co.kr
Heatmap analysis for Profound Medical Corp. and competitorsCPI Data & Risk Controlled Swing Trade Alerts - Newser
Tick level data insight on Profound Medical Corp. volatilityMarket Sentiment Review & Verified Technical Trade Signals - Newser
Risk adjusted return profile for Profound Medical Corp. analyzedTrade Volume Report & Risk Controlled Stock Pick Alerts - Newser
How to integrate Profound Medical Corp. into portfolio analysis toolsQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - Newser
Profound Medical Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Profound Medical's Market Cap Drops To CA$227m Leaving Insiders With Losses - simplywall.st
Profound Medical Reports Q2 2025 Growth and New Innovations in Prostate Treatment - MSN
Candlestick signals on Profound Medical Corp. stock today2025 Dividend Review & Consistent Return Strategy Ideas - Newser
Profound Medical Corp. shares fall 21.66% intraday after posting a wider loss for Q2 2025. - AInvest
Profound Medical's 21.66% Plunge: A Bearish Surge Amid Sector Turbulence? - AInvest
Profound Medical Corp Q2 2025 Earnings: Revenue Misses Estimate, EPS at -$0.52 - AInvest
ProFound Medical's Strategic Reimagining: Navigating the Urology Medtech Landscape for Long-Term Value - AInvest
Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Profound Medical Announces Second Quarter 2025 Financial Results - 富途牛牛
Is Profound Medical Corp. the Top Chart Pick This WeekEarnings Overview Report & Consistent Return Investment Signals - thegnnews.com
ProFound Medical's Strategic Pivot: Capital Sales and the Road to Sustainable Growth in 2025 - AInvest
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
Profound Medical Corp Stock (PROF) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
0.09%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):